Blog

The Woodruff Lab contributes to the Women’s Health Research Institute and Oncofertility Consortium blogs. Read the latest information disseminated from these blogs below:  

Increasing Awareness and Access to Oncofertility Care

Oncofertility colleagues, Drs. Richard Anderson and Melanie Davies from the UK recently published an editorial in The BMJ encouraging specialists across the UK to standardize fertility preservation interventions since awareness about fertility preservation remains relatively low. Despite national guidelines, obstacles still remain in terms of need for funding and access to care.
Read the complete article here:  

A Medical Student's Experience from the 2016 Oncofertility Conference

Each year the Oncofertility Conference brings together a diverse group of professionals who all share a passion for oncofertility. Oncofertility is a field that brings together a variety of different disciplines, backgrounds, and levels of experience. All conference attendees are encouraged to interact freely and it is not unusual to see an attending physician with 25 years experience engaged in a conversation with a first year postdoc, a high school student, and a humanities scholar. Alot can be learned from each other and it is important we continue to educate the next generation of oncofertility leaders.

Below is a personal experience from Austin Armstrong, a second year medical student from the University of Kansas School of Medicine-Wichita, who attended this year's conference for the first time.  

Announcement from Brazil

The Oncofertility Consortium congratulates Dr. Joao Pedro Caetano who is the newly elected president of the Brazilian Society of Human Reproduction.  The Brazilian Society of Human Reproduction was founded 70 years ago and is the most active organization in the region, bringing together physicians, scientists and allied health professionals in the field of human reproduction. 

Oncofertility Resources Available in Turkish

As part of the Oncofertility Consortium's ongoing efforts to provide native language resources to patients and providers around the world, SaveMyFertility.org is now available in Turkish. Global Partner, Dr. Ayse Arvas from Onkofertilite Turkiye recently translated these resources and they are all available online now. This includes:

Fertility Preservation for Children Diagnosed with Cancer - Kanser Teşhisi Gören Çocuklar İçin Doğurganlık Koruma

New Publication from Portuguese Global Partners

Congratulations to our colleagues in Portugal who recently published a paper in Human Reproduction. The paper Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis appeared in the September online issue of the journal. To read the article it its entirety, click here

Presentations from the 2016 Oncofertility Conference Now Online!!

Thank you all for attending the 2016 Oncofertility Conference.  This marked the 10th anniversary of the Oncofertility Conference and it was such a success. Thank you to all our speakers for giving such great talks and thanks to all our attendees who made this conference truly memorable. This year was highlighted by a full day of education sessions on November 1, followed by two full days of lectures. All of the lectures from November 2 and 3 are now permanently archived online for anyone to watch anytime! Please enjoy these videos and we look forward to seeing you all next year for the 11th Annual Oncofertility Conference on November 14-16, 2017!  

Watch the presentations from the 2016 Oncofertility Conference here

New Publication from German Global Partner

Congratulations to our partners in Germany who recently published in Reproductive Biology and Endocrinology. Many of the authors are members of the Research Group for Reproductive Medicine, Medical Faculty, Cologne University. Below are details about the paper and a link to access the full publication. 

Cryopreservation and xenografting of human ovarian fragments: medulla decreases the phosphatidylserine translocation rate.
Vladimir Isachenko, Plamen Todorov, Evgenia Isachenko, Gohar Rahimi, Bettina Hanstein, Mahmoud Salama, Peter Mallmann, Andrey Tchorbanov, Paul Hardiman, Natalie Getreu and Markus Merzenich
http://rbej.biomedcentral.com/articles/10.1186/s12958-016-0213-6

Survivors of Childhood Cancer POI Surveillance Recommendations

This report represents a unique collaborative effort among international specialists in the field of oncology and reproductive medicine. An evidence based approach was used to develop recommendations regarding surveillance for premature ovarian insufficiency in female childhood, adolescent and young adult cancer survivors.  In particular, because females exposed to specific gonadotoxic treatments including alkylating agents and ovarian radiation are at highest risk for ovarian insufficiency, these survivors should be monitored closely before and after puberty. The focus of monitoring should be on growth, pubertal development, assessment of menstrual function and measurement of serum FSH and Estradiol. The authors concluded that AMH may be a reasonable adjunct for assessing ovarian reserve in women at least 25 years of age.

Fertility Drugs and Cancer Guideline Issued by ASRM

Recently the American Society for Reproductive Medicine issued a new guideline assessing the impact of fertility drugs on the risk of cancer in women. This guideline was developed after a comprehensive literature search and grading the available data on this topic. The committee concluded that data in this area are limited by retrospective observational studies which have a variety of methodological problems including: small sample sizes, inadequate information about duration and dose of fertility treatment, and limited follow-up. Moreover, the data are confounded by the fact that some women with infertility are at increased risk of breast, ovarian and endometrial cancer. Nonetheless, there is no compelling data suggesting that fertility medications increase the risk of invasive cancers.